SCI Pharmtech Incorporated

Greenhouse gas emissions & sustainability report data

πŸ“Š Latest report period: 2020-2021πŸ—‚οΈ Report periods on file: 2020-2021, 2016-01 to 2017-12

In its 2020-2021 reporting, SCI Pharmtech Incorporated disclosed greenhouse gas emissions of 16.3K tCO2e (2020); 1644 tCO2e (2021). Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

πŸ’¨
GHG Emissions
16.3K tCO2e (2020); 1644 tCO2e (2021)
2020-2021
πŸ’§
Water Usage
539.0K tons (2020); 28000 tons (2021)
2020-2021
♻️
Waste
4.6K tons (2020); 3987.4 tons (2021)
2020-2021
βš™οΈ
Energy Use
182.7K GJ (2020); 11957.28 GJ (2021)
2020-2021

πŸ“ˆ Emissions by Report Period

Report periodHeadline emissions figure reported
2020-202116.3K tCO2e (2020); 1644 tCO2e (2021)
2016-01 to 2017-126.1K tCO2e/year (2017)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

βœ… Reported Environmental Achievements

🎯 Climate & Sustainability Targets

πŸ”œ Short-term

  • Recover majority production capacity by 2022 and maintain close customer relationships.
  • Increase production capacity to 60% by 2022; resolve compensation issues in 2022.

πŸ“… Medium-term

  • Diversify production bases and maintain operation flexibility.
  • Fully repair production lines and improve productivity.

πŸ”­ Long-term

  • Promote circular economy and jointly work towards sustainability.
  • Cooperate with the Guanyin Plant to maximize production capacity and create record-breaking revenues.

🌱 ESG Focus Areas

Disaster RecoveryOccupational Safety and HealthEconomic PerformanceCustomer Health and SafetyWastewater and WasteEnergy Management and GHG EmissionsOperation IntegrityLabor-Employer Relations

⚠️ Challenges & Risks +

  • Major fire accident at the end of 2020, resulting in casualties, production shutdown, and supply chain disruptions.
  • Global COVID-19 pandemic causing supply chain disruptions and increased material costs.
  • Difficulty in treating wastewater and waste from pharmaceutical production.
  • Need to reduce energy consumption and carbon emissions to meet environmental regulations and market demands.

πŸ“‹ Report Information

Reporting Period: 2020-2021
Frameworks: GRI Standards 2016
Assurance: KPMG (financial data)